Search icon
Learn, Analyse & Invest
only with
Orca logoArrow icon
+91
Download Orca
orca play storeorca apple store
To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

Sampre Nutritions Ltd.

Sampre Nutritions

0.00

0.00 (0.00)%

NSE

BSE

EX-DatePurpose
29 06 2021 Audited Results
12 08 2021 Quarterly Results
12 11 2021 Quarterly Results
02 02 2022 Quarterly Results
10 03 2022 Right Issue of Equity Shares & Increase in Authorised Capital Inter alia, to consider following business: a. Increase in Authorised Share Capital of the Company b. Further issue of shares by way of Rights issue/preferential issue.
28 05 2022 Audited Results
15 07 2022 Preferential Issue of shares & Issue Of Warrants Inter alia, to consider further issue of shares / convertible warrants by way of preferential allotment.
06 08 2022 Quarterly Results
20 09 2022 Inter alia, to consider and approve further raising of FCCB upto 100 million $ in one or more tranches to finance the capital and working capital for overseas expansion by way of preferential allotment.
07 10 2022 Inter alia, to consider and approve and decide upon alternatives to increase the production capacities by way of identifying and acquiring running plant with production capacities meeting quantity and quality requirements of the company or though greenfield investment options.
12 11 2022 Quarterly Results
09 02 2023 Quarterly Results
30 05 2023 Audited Results
14 08 2023 Quarterly Results
14 11 2023 Quarterly Results & Preferential Issue of shares
12 02 2024 Quarterly Results
14 11 2024 Quarterly Results & Preferential Issue of shares
13 02 2025 Quarterly Results & Preferential Issue of shares
28 02 2025 Cancelled Board Meeting (Cancelled)
30 05 2025 Audited Results(Cancelled) (Cancelled)
04 06 2025 Audited Results
18 07 2025 Quarterly Results
25 08 2025 A.G.M.
19 09 2025 Stock Split & Bonus issue
03 10 2025 Inter alia to transact the following items:- 1. To offer, issue and allot securities by way of preferential allotment. 2. To approve issuance of foreign currency convertible bonds (FCCBs).
05 11 2025 Quarterly Results & Preferential Issue of shares & Inter alia, to consider and approve to issue equity shares by way of sweat equity; and conversion of loan into equity shares.

News

18-OCT-2025

Sampre Nutritions inks pact with Reliance Consumer Products

The agreement is expected to generate a business of Rs 12 to Rs 15 crore annually over a tenure of 3 years

10:01 AM
23-AUG-2025

Sampre Nutritions enters into manufacturing agreement with Rama Exports

The agreement is expected to generate a business of RS 15 crore over the term of the contract

10:44 AM
Enrich money logo